Efficient enzymatic degradation used as pre-stage treatment for norfloxacin removal by activated sludge.

Bioprocess Biosyst Eng

School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an, 710062, People's Republic of China.

Published: August 2017

Norfloxacin is often found in wastewater treatment plants, groundwater, and even drinking water causing environmental concerns because of its potential undesirable effects on human health or aquatic ecosystems. However, conventional treatments cannot deal with norfloxacin efficiently. This work proposes an efficiently enzymatic degradation of norfloxacin by chloroperoxidase (CPO). 82.18% degradation efficiency of norfloxacin was achieved after 25 min reaction time at pH 5.0 with an enzyme concentration of 1.5 × 10 mol L. HPLC-MS was used to determine the intermediates or final products. The product analysis and determination of the chemical oxygen demand indicated if the enzymatic degradation by CPO was carried out before the usually existing bioremediation techniques (usually activated sludge) in sewage treatment plant, the effluent containing norfloxacin can be decontaminated more efficiently and thoroughly than that only by activated sludge treatment. The eco-toxicity tests using a green algae, Chlorella pyrenoidosa, indicated that the toxicity of degraded products of norfloxacin was lower than the parent norfloxacin molecule. CPO-catalyzed degradation of norfloxacin is a promising alternative for treating effluent containing norfloxacin.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00449-017-1786-yDOI Listing

Publication Analysis

Top Keywords

enzymatic degradation
12
activated sludge
12
norfloxacin
10
degradation norfloxacin
8
effluent norfloxacin
8
degradation
5
efficient enzymatic
4
degradation pre-stage
4
treatment
4
pre-stage treatment
4

Similar Publications

LC-HRMS screening procedure for the detection of 11 different classes of prohibited substances in dried urine spots for doping control purposes.

Anal Bioanal Chem

January 2025

Doping Control Laboratory, Department of Diagnostic Sciences, Ghent University, Block B, Ottergemsesteenweg 460, BE-9000, Ghent, Belgium.

Dried urine spots have recently been proposed as an alternative matrix in the anti-doping field. Drying urine may open the opportunity to limit microbial and thermal degradation of the prohibited substances during transportation to the anti-doping laboratories without the need for refrigeration or freezing. In this study, a multi-targeted initial testing procedure was developed for the determination of 237 prohibited drugs/metabolites from 11 different classes in dried urine spots.

View Article and Find Full Text PDF

Fructose-1,6-bisphosphatase 1 (FBP1) is a key gluconeogenic enzyme that plays complex and context-dependent roles in cancer biology. This review comprehensively examines FBP1's dual functions as both a tumor suppressor and an oncogene across various cancer types. In many cancers, such as hepatocellular carcinoma, clear cell renal cell carcinoma, and lung cancer, downregulation of FBP1 contributes to tumor progression through metabolic reprogramming, promoting glycolysis, and altering the tumor microenvironment.

View Article and Find Full Text PDF

Tattooing is a popular form of body art that has evolved from ancient times into being part of modern society. The understanding of biotransformation processes of coloring tattoo pigments in human skin is limited although skin reactions to tattoos with unknown culprits occur. Electrochemistry coupled to mass spectrometry (EC-MS) has widely been used as a tool for a purely instrumental approach to simulating the enzymatic biotransformation of xenobiotics.

View Article and Find Full Text PDF

The TRAMP complex contains two enzymatic activities essential for RNA processing upstream of the nuclear exosome. Within TRAMP, RNA is 3' polyadenylated by a subcomplex of Trf4/5 and Air1/2 and unwound 3' to 5' by Mtr4, a DExH helicase. The molecular mechanisms of TRAMP assembly and RNA shuffling between the two TRAMP catalytic sites are poorly understood.

View Article and Find Full Text PDF

Background: The prion model of tau propagation in Alzheimer's Disease predicts that tau seeds are released from cells and taken up by neighboring cells, resulting in spreading of the disease. Our previous work revealed that tau aggregates bind to heparan sulfate proteoglycans (HSPGs) on the cell surface, followed by cellular uptake via macropinocytosis. HSPGs are glycoproteins, consisting of a protein core and decorated with linear glycosaminoglycan (GAG) chains called heparan sulfate (HS) with highly variable sulfation patterns.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!